Iron(III)‐tCDTA derivatives as MRI contrast agents
dc.contributor.author | Xie, Jing | |
dc.contributor.author | Haeckel, Akvile | |
dc.contributor.author | Hauptmann, Ralf | |
dc.contributor.author | Ray, Iweta Pryjomska | |
dc.contributor.author | Limberg, Christian | |
dc.contributor.author | Kulak, Nora | |
dc.contributor.author | Hamm, Bernd | |
dc.contributor.author | Schellenberger, Eyk | |
dc.date.accessioned | 2021-03-01T12:26:23Z | |
dc.date.available | 2021-03-01T12:26:23Z | |
dc.date.issued | 2021-02-04 | none |
dc.date.updated | 2021-02-22T14:09:47Z | |
dc.identifier.uri | http://edoc.hu-berlin.de/18452/23145 | |
dc.description.abstract | Purpose Low molecular weight iron(III) complex‐based contrast agents (IBCA) including iron(III) trans‐cyclohexane diamine tetraacetic acid [Fe(tCDTA)]− could serve as alternatives to gadolinium‐based contrast agents in MRI. In search for IBCA with enhanced properties, we synthesized derivatives of [Fe(tCDTA)]− and compared their contrast effects. Methods Trans‐cyclohexane diamine tetraacetic acid (tCDTA) was chemically modified in 2 steps: first the monoanhydride of Trans‐cyclohexane diamine tetraacetic acid was generated, and then it was coupled to amines in the second step. After purification, the chelators were analyzed by high‐performance liquid chromatography, mass spectrometry, and NMR spectrometry. The chelators were complexed with iron(III), and the relaxivities of the complexes were measured at 0.94, 1.5, 3, and 7 Tesla. Kinetic stabilities of the complexes were analyzed spectrophotometrically and the redox properties by cyclic voltammetry. Results Using ethylenediamine (en) and trans‐1,4‐diaminocyclohexane, we generated monomers and dimers of tCDTA: en‐tCDTA, en‐tCDTA‐dimer, trans‐1,4‐diaminocyclohexane‐tCDTA, and trans‐1,4‐diaminocyclohexane‐tCDTA‐dimer. The iron(III) complexes of these derivatives had similarly high stabilities as [Fe(tCDTA)]−. The iron(III) complexes of the trans‐1,4‐diaminocyclohexane derivatives had higher T1 relaxivities than [Fe(tCDTA)]− that increased with increasing magnetic field strengths and were highest at 6.8 L·mmol−1·s−1 per molecule for the dimer. Remarkably, the relaxivity of [Fe(en‐tCDTA)]+ had a threefold increase from neutral pH toward pH6. Conclusion Four iron(III) complexes with similar stability in comparison to [Fe(tCDTA)]− were synthesized. The relaxivities of trans‐1,4‐diaminocyclohexane‐tCDTA and trans‐1,4‐diaminocyclohexane‐tCDTA‐dimer complexes were in the same range as gadolinium‐based contrast agents at 3 Tesla. The [Fe(en‐tCDTA)]+ complex is a pH sensor at weakly acidic pH levels, which are typical for various cancer types. | eng |
dc.description.sponsorship | DFG | |
dc.language.iso | eng | none |
dc.publisher | Humboldt-Universität zu Berlin | |
dc.rights | (CC BY-NC-ND 4.0) Attribution-NonCommercial-NoDerivatives 4.0 International | ger |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | gadolinium | eng |
dc.subject | iron chelate | eng |
dc.subject | iron oxide nanoparticles | eng |
dc.subject | low‐molecular‐weight iron(III)‐based contrast agents | eng |
dc.subject | magnetic resonance imaging | eng |
dc.subject | nephrogenic systemic fibrosis | eng |
dc.subject.ddc | 610 Medizin und Gesundheit | none |
dc.title | Iron(III)‐tCDTA derivatives as MRI contrast agents | none |
dc.type | article | |
dc.subtitle | Increased T1 relaxivities at higher magnetic field strength and pH sensing | none |
dc.identifier.urn | urn:nbn:de:kobv:11-110-18452/23145-4 | |
dc.identifier.doi | 10.1002/mrm.28664 | none |
dc.identifier.doi | http://dx.doi.org/10.18452/22527 | |
dc.type.version | publishedVersion | none |
dc.type.version | publishedVersion | none |
local.edoc.container-title | Magnetic Resonance in Medicine | none |
local.edoc.pages | 13 | none |
local.edoc.type-name | Zeitschriftenartikel | |
local.edoc.institution | Mathematisch-Naturwissenschaftliche Fakultät | none |
local.edoc.container-type | periodical | |
local.edoc.container-type-name | Zeitschrift | |
local.edoc.container-publisher-name | Wiley | none |
local.edoc.container-publisher-place | New York | none |
local.edoc.container-volume | 85 | |
local.edoc.container-issue | 6 | |
local.edoc.container-firstpage | 3370 | |
local.edoc.container-lastpage | 3382 | |
dc.description.version | Peer Reviewed | none |
dc.description.version | Peer Reviewed | none |
local.edoc.affiliation | Xie, Jing; Department of Radiology Charité–Universitätsmedizin Berlin Berlin Germany | none |
local.edoc.affiliation | Haeckel, Akvile; Department of Radiology Charité–Universitätsmedizin Berlin Berlin Germany | none |
local.edoc.affiliation | Hauptmann, Ralf; Department of Radiology Charité–Universitätsmedizin Berlin Berlin Germany | none |
local.edoc.affiliation | Ray, Iweta Pryjomska; Department of Chemistry Humboldt‐Universität zu Berlin Berlin Germany | none |
local.edoc.affiliation | Limberg, Christian; Department of Chemistry Humboldt‐Universität zu Berlin Berlin Germany | none |
local.edoc.affiliation | Kulak, Nora; Institute of Chemistry Otto‐von‐Guericke‐Universität Magdeburg Magdeburg Germany | none |
local.edoc.affiliation | Hamm, Bernd; Department of Radiology Charité–Universitätsmedizin Berlin Berlin Germany | none |